The diagnosis of dystroglycanopathies often involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can confirm mutations in the dystroglycan gene or related genes involved in its glycosylation. A muscle biopsy may reveal characteristic changes in the muscle fibers, such as reduced dystroglycan expression.
